RxDoctor Payments Data

Phillip Guillen, MD

Hand Surgery · Smithtown, NYNPI 1568781268

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Polaris Technology Solutions LLC at 24.3% of the total. 2025 is the largest year on record at $2,677, 8.9 times the $302 reported in 2019.

$5,669in general payments, 2019–2025

Across 95 payments — averaging $59.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Polaris Technology Solutions LLC$1K
  • Arthrex$1K
  • Linvatec Corporation$1K
  • Zimmer Biomet$416
  • Endo Pharmaceuticals Inc.$295
  • Johnson & Johnson$291
  • plus $964 from 10 others

What the payments were for

  • Travel & lodging$2,31341%
  • Food & beverage$3,21757%
  • Education$1392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,669 in reported general payments places this provider in the 70th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York

Medicare billing

Part B allowed, 2024
$150,450
Medicare patients
193
Services billed
856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium51$565

Paid to pharmacies, not to this prescriber.

Other hand surgery in Smithtown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →